Previous studies have demonstrated that mTOR inhibitors reduce inflammation in cystic fibrosis (CF)80–82, while reduced ubiquitin-mediated proteolysis has been linked to decreased inflammation and increased CFTR cell surface expression83,84. This evidence concerns the gene UBC and cystic fibrosis.